Press Releases

Date Title and Summary Additional Formats
Toggle Summary Quotient Limited to Host Key Opinion Leader Webinar on its MosaiQ™ Solution
Virtual event on Monday, May 23 rd at 11:00 AM ET The webinar will provide a detailed discussion on the current landscape and unmet needs within blood grouping and donor disease screening JERSEY, Channel Islands , May 12, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage
View HTML
Toggle Summary Quotient Limited Announces Appointment of New Board Member
JERSEY, Channel Islands , April 26, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the appointment of Thomas Aebischer to Quotient Board of Directors effective as of May 1, 2022 . Mr. Aebischer will also serve on the Board's Audit
View HTML
Toggle Summary Quotient Limited Further Strengthens Scientific and Medical Synergies with the Expansion of the MosaiQ Innovator’s Circle
New York Blood Center, Inc. and Centro de Transfusiones de la Comunidad de Madrid join MosaiQ’s Innovator’s Circle in partnership to improve patient care and laboratory efficiencies JERSEY, Channel Islands , March 21, 2022 (GLOBE NEWSWIRE) -- Quotient Limited  (NASDAQ:QTNT), a commercial-stage
View HTML
Toggle Summary Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology Microarray
The Extended Immunohematology microarray provides labs with comprehensive characterization, simplified workflow, and high throughput—all on a single multimodal multiplexing platform JERSEY, Channel Islands , March 08, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage
View HTML
Toggle Summary Quotient Limited to Participate in the Cowen 42nd Annual Health Care Conference
JERSEY, Channel Islands , Feb. 22, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the management team will participate in the Cowen 42nd Annual Health Care Conference .
View HTML
Toggle Summary Quotient Limited Reports Third Quarter Fiscal 2022 Results and Provides Business Update
MosaiQ™ Solution: Transfusion Diagnostics : The Notified Body completed the assessment of the Company’s technical dossier and has advised that it will recommend the MosaiQ Expanded Immunohematology (IH) microarray for CE marking approval; Commercial Execution: In anticipation of CE marking, the
View HTML
Toggle Summary Quotient Limited to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
JERSEY, Channel Islands , Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced that the management team will participate in the virtual BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference .
View HTML
Toggle Summary Quotient Limited Announces Equity Awards
JERSEY, Channel Islands , Feb. 02, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced the scheduled grant of equity awards to Mr. Esteban Uriarte , who has been appointed as the Chief Manufacturing Operations Officer of the
View HTML
Toggle Summary Quotient Limited Provides MosaiQ Regulatory & Commercial Update
The company remains in contact with the European Notified Body and continues to anticipate approval in Q1 CY22 First time attendance to Arab Health and Medlab Middle East 2022 in Dubai Generated traction on MosaiQ solution from potential distributors JERSEY, Channel Islands , Feb.
View HTML
Toggle Summary Quotient Limited to Report Third Quarter Fiscal Year 2022 Financial Results and Host Conference Call
JERSEY, Channel Islands , Jan. 31, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2021 will be released before market open on Tuesday, February 8, 2022 .
View HTML